logo
Plus   Neg
Share
Email

Evotec, Bayer In New Deal To Develop PCOS Treatment Options - Quick Facts

Evotec AG (EVTCY.PK,EVOTF.PK) announced Thursday a new five-year, multi-target partnership with Bayer AG to develop multiple clinical candidates for the treatment of polycystic ovary syndrome or PCOS.

Under the terms of the agreement, both companies will contribute drug targets and a comprehensive set of high-quality technology platforms to jointly develop innovative treatment options.

Bayer and Evotec will share responsibilities during the pre-clinical development of potential clinical candidates. Bayer will be responsible for any subsequent clinical development and commercialisation.

Under the deal, Evotec will receive 6.5 million euros upfront payment and 10 million euros research payments over five years. In addition, Evotec might be eligible to receive pre-clinical, clinical and sales milestones of potentially over 330 million euros as well as royalties up to low double-digit percentages of net sales.

The strategic alliance will also have access to targets from the recently formed partnership between Evotec and Celmatix, a company engaged in data-driven target discovery focused on fertility and women's health.

In 2012, Bayer and Evotec entered their first strategic five-year, multi-target alliance developing treatment options for endometriosis.

A second research alliance was initiated in 2016 to develop multiple clinical candidates for the treatment of kidney diseases.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla said it will produce ventilators at its Gigafactory in Buffalo, New York to support the city's hospitals amid the coronavirus pandemic. New York is the worst affected state in the U.S. Last Saturday, Musk tweeted that he "had a long engineering discussion with Medtronic about state-of-the-art ventilators. Luxury fashion house Ralph Lauren will donate $10 million to help fight the coronavirus pandemic and manufacture face masks as well as medical gowns in the U.S. The company's charity arm, the Ralph Lauren Corporate Foundation, said in a statement that it is committing $10 million towards the global response to the COVID-19 pandemic. General Motors Co. is delaying work on new vehicle models and is cutting pay for its executives as part of efforts to conserve cash amid the coronavirus or Covid-19 pandemic. The automotive giant also extended the shutdown of North American plants indefinitely. Multiple reports cited an internal memo that salaried workforce will have 20 percent of pay deferred starting April 1.
Follow RTT
>